Uncategorized
Rocket 4 efficacy trial for Rhopressa underway
Aerie Pharmaceuticals announced the first patient was dosed in a fourth phase 3 clinical trial of Rhopressa, according to a press release.Rhopressa is a triple-action eye drop undergoing testing for its ability to lower IOP in patients with glaucoma or ocular hypertension.